Literature DB >> 1958590

Cytogenetics of papillary renal cell tumors.

G Kovacs1, L Fuzesi, A Emanual, H F Kung.   

Abstract

Chromosome aberrations were determined in short-term cultures of 18 papillary renal cell tumors, as well as in the cell line ACHN, and the results were evaluated together with 20 previously published cases. We found that chromosomes 7, 17, and 16 and the Y chromosome were specifically involved in the karyotype changes, marks benign papillary renal cell adenomas (ten cases). Malignant papillary renal cell carcinomas (29 cases) were characterized by additional trisomies: trisomy 16 occurred in 20 tumors, and trisomy 12 and 20 in 8 tumors each. Loss of the Y chromosome was observed in 7 of 9 benign and in 23 of 25 malignant tumors that developed in males. None of the papillary renal cell adenomas or carcinomas showed a loss of 3p or gain of a 5q segment, both of which are characteristic of common non-papillary renal cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958590     DOI: 10.1002/gcc.2870030403

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  46 in total

1.  Expression of osteopontin and CD44 molecule in papillary renal cell tumors.

Authors:  Koviljka Matusan; Gordana Dordevic; Vladimir Mozetic; Ksenija Lucin
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

2.  Sciellin is a marker for papillary renal cell tumours.

Authors:  Anetta Nagy; Daniel Banyai; David Semjen; Tamas Beothe; Gyula Kovacs
Journal:  Virchows Arch       Date:  2015-10-16       Impact factor: 4.064

3.  Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases.

Authors:  Yves Allory; Delphine Ouazana; Eric Boucher; Nicolas Thiounn; Annick Vieillefond
Journal:  Virchows Arch       Date:  2003-04-04       Impact factor: 4.064

Review 4.  Renal cell carcinoma.

Authors:  Paul Cairns
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 5.  Molecular biology of testicular germ cell tumors: current status.

Authors:  B Schmidt; R Ackermann; T Strohmeyer
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

6.  Epidermal growth factor receptor gene expression and binding capacity in renal cell carcinoma, in relation to tumor stage, grade and DNA ploidy.

Authors:  B Ljungberg; M Gåfvels; J E Damber
Journal:  Urol Res       Date:  1994

7.  SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma.

Authors:  Yun-Chen Chiang; In-Young Park; Esteban A Terzo; Durga Nand Tripathi; Frank M Mason; Catherine C Fahey; Menuka Karki; Charles B Shuster; Bo-Hwa Sohn; Pratim Chowdhury; Reid T Powell; Ryoma Ohi; Yihsuan S Tsai; Aguirre A de Cubas; Abid Khan; Ian J Davis; Brian D Strahl; Joel S Parker; Ruhee Dere; Cheryl L Walker; W Kimryn Rathmell
Journal:  Cancer Res       Date:  2018-05-03       Impact factor: 12.701

Review 8.  Diagnosis and prognosis of renal-cell tumors: a molecular approach.

Authors:  M Wilhelm; U Krause; G Kovacs
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 9.  The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours.

Authors:  G Kovacs
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

10.  [Tumor profiling of renal cell tumors: relevance for diagnostics and therapy].

Authors:  K Junker; T Steiner; J Sanjmyatav; R Pilchowski; C Heinze; M Walter; J Schubert
Journal:  Pathologe       Date:  2009-03       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.